Inactive

Background: On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic, and on March 13, 2020, the United States issued a Presidential Proclamation declari... Background: On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic, and on March 13, 2020, the United States issued a Presidential Proclamation declaring the COVID-19 outbreak to be a national emergency. Additionally, all fifty states and the District of Columbia have declared emergencies due to COVID-19. Because COVID-19 is an emerging disease, and there are no vaccines or approved treatments, it is prudent to have adequate flexibility to address this public health emergency. The Department of Health and Human Services (HHS) has a requirement to provide medical and pharmaceutical related material and services to various locations across the US during this public health emergency and response effort. The Department anticipates receiving Mission Assignments generated from within and outside HHS to purchase and distribute required services, products and equipment. Any delay in providing critical medical supplies, services and equipment could cause irreparable harm and put American citizens at an increased risk of transmission and exposure. Every effort must be made to provide needed products and services in the most expedient manner. HHS is working in tandem with other Federal Agencies which, among others, are providing disaster medical assistance teams to provide medical relief and assistance to areas impacted by COVID-19. In support of these efforts, HHS has an urgent need to obtain supplies and services to ensure the delivery of potentially lifesaving and preventative medical supplies and services in support of the response to the COVID-19 pandemic. J&A Description: This notice is a class Justification & Approval (J&A) in accordance with FAR § 6.303-1(d) and 6.302-2, Unusual and Compelling Urgency, FAR § 8.405-6(a)(1)(A), Limiting Sources, and FAR § 16.505(b)(2)(i)(A), Exceptions to the Fair Opportunity Process for all contract actions to facilitate the recovery efforts necessary to address the 2019 Novel Coronavirus (COVID-19). This class J&A is essential to respond to urgent requests for immediate support to respond to the expanding outbreak of COVID-19 which was just declared a global pandemic on March 11, 2020 and a national emergency via Presidential Proclamation on March 13, 2020. This class J&A supersedes all other class J&A’s executed and issued by HHS and negates the need for individual J&As for contract actions to facilitate the recovery efforts necessary to address COVID-19. Award Requirement types: Please note: The listed Product Service Code, General Health Care Services (Q201), is not the only PSC that applies to this notice. PSC code Q201 was listed because of the data field requirements for posting notices on beta.sam.gov AND as a general point of reference. Research & development (R&D) R & D support services Support services (non-R&D) Supplies/equipment Information technology (IT) Construction Architect-engineer (A & E) services Design-build Other (specify): Additional requirements as needed to support recovery efforts related to this national emergency Award Action Type: New Requirement For more Information on award activity under this J&A, please see the attached FULL class justification & Approval located in the attachments section.